A Randomized, Open-labelled and Controlled Clinical Trial to Investigate the Clinical Efficacy of Isoquercetin in the Treatment of Mild-to-moderate Hospitalised COVID-19 Patients
Latest Information Update: 07 Feb 2023
At a glance
- Drugs Isoquercetin (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 10 Feb 2021 Status changed from planning to not yet recruiting.
- 29 Jan 2021 New trial record